Supplier Type
- Manufacturer
- Trader
- custom synthesis
- Reagent
- contract manufacturer
Supplier Region
- Hyderabad(19)
- Gujarat(26)
- Maharashtra(15)
- New Delhi(2)
- Andhra Pradesh(1)
- Beijing(1)
- Bangalore(2)
- Telangana(2)
- Ahmedabad(18)
- Pune(3)
- Vadodara(12)
- Karnataka(7)
- Mumbai(41)
- Uttar Pradesh(5)
- Delhi(10)
- Madhya Pradesh(3)
- Kolkata(5)
- Rajasthan(1)
- Nagpur(3)
- Haryana(2)
- Punjab(1)
Purity
- yes
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Purity
- NLT 99%
- NLT 95%
- NLT 90%
- More than 98%
- more than 95%
- more than 90%
- MINIMUM 99%
- Min.96%
- Min. 35.0%
- Min 98 %
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Magnesium content 8.49% to 8.84%
- Magnesium content 4.0-5.0%
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Chemically pure
- Bismuth Content 56.0 %
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.9%
- 99.88%
- 99.86%
- 99.85%
- 99.84%
- 99.81%
- 99.80%
- 99.8%
- 99.73%
- 99.70%
- 99.69%
- 99.61%
- 99.6
- 99.55%
- 99.50%
- 99.5% to 100.5%
- 99.47%
- 99.42%
- 99.40%
- 99.39%
- 99.29%
- 99.28%
- 99.27%
- 99.21%
- 99.19%
- 99.10%
- 99.00%
- 99.0%
- 99.0 &100.5
- 99.0 % - 101.0 %
- 99% Pure
- 99% Minimum
- 99% min
- > 99%
- 99%
- >99%
- 99 %
- 99
- 98=%
- 98+
- 98.94%
- 98.88%
- 98.65%
- 98.60%
- 98.54%
- 98.53%
- 98.50%
- 98.5 to 101.5%
- 98.5
- 98.34%
- 98.18%
- 98.12%
- 98.08%
- 98.00%
- 98.00 % - 102.00 %
- 98.0% to 101.0%
- 98.0% - 102.0%
- 98.0 % -102.0 %
- 98.0 % - 100.5 %
- 98.0 - 100.5%
- 98% Minimum
- 98% Min.
- 98% Min
- >98%
- 98%
- 98 % min
- 97-99%
- 97.84%
- 97.61%
- 97.57%
- > 97.5 %
- 97.00%
- 97% min
- >97%
- 97%
- 97 %
- 96.80%
- > 96.5 %
- 96.5 - 103.5 %
- 96.40%
- 96.39%
- 96.14%
- 96.00 % Min
- 96%
- 95-98%
- 95.48%
- 95.16%
- 95.00%
- 95.00 % Min
- 95% min
- 95%
- >95%
- 94.34%
- 94.00%
- 93.0 % Min
- 93 %- 101%
- 92-95%
- >92%
- 91.87%
- 90-95%
- 90%-95%
- >90%
- 90%
- 90 % Min.
- 90 % Above
- 89%
- 86.0 % - 89.0 %
- 85 percent Min
- 84.49%
- 80
- 75 %
- 68.0 % Min
- 65%
- 40
- 14.5 - 16.0%
- 100% Pure
- 100%
- 0.04%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 1g
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 250250 mg.
- 11Between 1 gm to 1 MT (As per availability)
-
FUROSEMIDE RELATED COMPOUND B (100 MG) (4-CHLORO-5-SULFAMOYLANTHRANILIC ACID)
3086-91-7
-
[2S-[1[R*(R*)],2α,3aβ,6aβ]]-1-[2-[[3-Cyclohexyl-1-(ethoxycarbonyl)propyl]aMino]-1-oxoprop
99742-35-5
-
Montelukast Bis-sulfide (Mixture of Diastereomers)
1187586-61-3
-
2-Acetamidophenol
614-80-2
-
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester)
35888-94-9
-
1-Keto Ketorolac
113502-52-6
-
Econazole Related Compound B as Nitrate
2724510-72-7
-
LANSOPRAZOLE SULFONE
131926-99-3
-
2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylthio-1H-benzimidazole
103577-40-8
